K, A., O, P., Z, W., DR, M., MR, T., Q, B., . . . MH, Q. (2024). Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation. British journal of haematology, 204(5), 1944. https://doi.org/10.1111/bjh.19384
Chicago Style (17th ed.) CitationK, Alzahrani, et al. "Impact of Revised International Staging System 2 Risk Stratification on Outcomes of Patients with Multiple Myeloma Receiving Autologous Haematopoietic Stem Cell Transplantation." British Journal of Haematology 204, no. 5 (2024): 1944. https://doi.org/10.1111/bjh.19384.
MLA (9th ed.) CitationK, Alzahrani, et al. "Impact of Revised International Staging System 2 Risk Stratification on Outcomes of Patients with Multiple Myeloma Receiving Autologous Haematopoietic Stem Cell Transplantation." British Journal of Haematology, vol. 204, no. 5, 2024, p. 1944, https://doi.org/10.1111/bjh.19384.